Support for Development of Vaccines against COVID-19

Support for Development of Vaccines against COVID-19

TRANSVAC is a collaborative infrastructure project funded by the European Commission. It is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI).

In order to support the fight against coronavirus disease 2019 (COVID19), TRANSVAC2 is encouraging researchers working on COVID19 to apply for the high-quality technical vaccine development services offered by the infrastructure.

With a few exceptions, services are free-of-charge. Some of the services COVID19 researchers may benefit from are:

Animal models

Adjuvant formulation

Clinical trial support

Regulatory support

The next deadline for applications is 15 April 2020.

​More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.